Boston Scientific target price cut to $44 from $48 by Citigroup
BSX•Citigroup cut its target price for Boston Scientific to $44 from $48.
Related News
CytoSorbents to report third-quarter 2026 financial results
CTSO•
Fractyl Health survey finds 33% of GLP-1 users prefer one-time procedure
GUTS•
Altisource Q3 2026 net loss narrows 42% to $1.4 million; revenue rises 24% to $51.9 million
ASPS•
VICI Properties: Stifel cuts target price to $30.75 from $34
VICI•
Insurance platform Hippo Holdings Q3 revenue beats estimates
HIPO•